mTOR activation in medullary thyroid carcinoma with RAS mutation.
Lyra J, Vinagre J, Batista R, Pinto V, Prazeres H, Rodrigues F, Eloy C, Sobrinho-Simões M, Soares P.
Lyra J, et al. Among authors: rodrigues f.
Eur J Endocrinol. 2014 Nov;171(5):633-40. doi: 10.1530/EJE-14-0389. Epub 2014 Aug 27.
Eur J Endocrinol. 2014.
PMID: 25163725